188
Participants
Start Date
February 28, 2013
Primary Completion Date
April 30, 2021
Study Completion Date
April 30, 2021
Spironolactone
"One tablet per day (25 mg Spironolactone/placebo) for the first three months. Subsequently dosage is increased to two tablets per day (50 mg Spironolactone/placebo) for the rest of the study.~In case of hyperkaliemia (\>5,5 mmol/L) or intolerable side effects dosage will be reduced to one tablet per day (25 mg Spironolactone/placebo)."
placebo
Odense University Hospital, Odense C
Fredericia Hosptial
OTHER
Odense University Hospital
OTHER